Background: In this study, we aimed to examine demographic and endoscopic features of patients with GI bleeding to determine the factors a ecting 30-day mortality. Method: Patient's demographic features, laboratory outcomes, comorbidities, drug use, endoscopy outcomes, Glasgow-Blatchford scores, and mortality status were examined. e factors a ecting 30-day mortality were investigated. Results: e mean age of the patients was 58.2±17.4 years, and 72.1% were male patients. 30-day mortality rate was found to be 14.4%. e mean age of patients who died was high (p<0.05). e incidence of mortality was high in the presence of comorbidity, malignancy, and cirrhosis (p<0.05). Systolic blood pressure was low in the patients who died (p<0.05). No signi cant correlation was found between mortality and gender, symptoms, predisposing factors, lesion type and Forrest score, diastolic blood pressure and heart rate (p>0.05). Urea, neutrophils, red blood cell distribution width / platelet ratio, neutrophil / lymphocyte ratio and RDW levels were high, and hemoglobin level was signi cantly low in patients with a mortal progression (p<0.05). No signicant correlation was found between mortality, and platelet and lymphocyte levels (p>0.05). Glasgow-Blatchford score was signi cantly higher in patients who died (p<0.05). Conclusion: Many factors a ect 30-day mortality in GI bleeding. It should be remembered that follow-up of patients with an advanced age who have comorbidity and impaired hemodynamics should be kept for long, and that these patients are at a high risk for mortality.
INTRODUCTION
Patients presenting to emergency departments with upper Gastrointestinal (GI) bleeding constitute a signi cant percentage of all emergency department admissions. Upper GI bleeding accounts for 80-85% of all cases of GI bleeding with an incidence of 50-150 per 100,000 persons (1) (2) (3) . Notably, 80% of patients with GI bleeding recover spontaneously without any intervention, and 20% of patients receive medical or surgical treatment (2, 3) . Despite advances in endoscopic and medical therapy, the mortality rate associated with this condition is 2-5% (4-6). Patients with massive upper GI bleeding may present to emergency departments with shock, as well as with symptomatic anemiasecondary to chronic blood loss. Given the high mortality rate associated with GI bleeding, rapid diagnosis and prompt treatment are important in such cases (7) . Although several factors are known to affect mortality rates in patients with upper GI bleeding, poor endoscopic outcomes and the severity of bleeding are the most important risk factors associated with mortality. e most important prognostic factor remains controversial (1) . We investigated the factors independently a ecting 30-day mortality rates in patients with GI bleeding.
MATERIALS AND METHODS
Following approval from the Local Ethics Committee of ŞişliEtfal Training and Research Hospital, we retrospectively investigated patients who presented to the emergency department. Patient details were obtained from the electronic medical record system of the hospital. We contacted patients' relatives in cases where the out-of-hospital mortality status of patients was unknown to con rm if those patients had survived and to obtain mortality details in the deceased.
Patient demographics, laboratory test results, comorbidities, drug use, endoscopy outcomes, Glasgow-Blatchford scores and mortality status were examined and factors a ecting 30-day mortality rates were investigated.
A er screening using the information processing system of the hospital, we included the following patients in the study: patients aged >18 years who presented with melena, hematemesis or hematochezia during physical examination in whom bleeding was con rmed to be GI bleeding and patients with GI bleeding de nitively diagnosed by endoscopic or colonoscopic examination. e following patients were excluded from the study: patients aged <18 years, those with suspected GI bleeding and patients in whom data pertaining to history, physical examination and laboratory tests were missing. e patients were divided into two groups as those who deceased within 30 days after gastrointestinal bleeding (Group2) and those who survived (Group 1).
Statistical Analysis
Data were analyzed using the SPSS 22.0 so ware. Parametric data were expressed as mean± standard deviation. Non-parametric data were expressed as medians and interquartile ranges, and qualitative data were expressed as frequencies and percentages. Normality of variables was evaluated using the Kolmogorov-Smirnov test.
e Student t-test was used to analyze parametric data, and the Mann-Whitney U test was used to analyse non-parametric data. e Chi-square and the Fischer exact test were used to analyze qualitative data. Multivariate logistic regression analysis was used to determine independent factors a ecting mortality rates. Receiver operating characteristic curve (ROC) analysis was performed to determine the e ectiveness of detecting mortality rates for neutrophil/ lymphocyte ratio (NLR) and the red blood cell distribution width (RDW). A p value <0.05 was considered statistically signicant.
RESULTS
is study included 111 patients. Notably,16 patients (14.4%) died within 30 days of developing upper GI bleeding. Mean age of the patients was 58.2±17.4 years and 72.1% were men (Table 1 ). e mean age of deceased patients was signi cantly high (p<0.05). No signi cant correlation was observed between mortality rates and sex (Table 1 ). e most common nding was melena (73%); however, no signi cant correlation was observed between mortality rates and all ndings (Table2) (p>0.05).
Among all patients included in the study, 60.4% reported comorbidities. e mortality rate was high in patients with comorbidities, malignancy, and cirrhosis (p<0.05) ( Table 1) . Predisposing factors were observed in 79.3% of patients; however, no signi cant correlation was observed between predisposing factors and mortality rates (p>0.05) ( Table 1) . Systolic blood pressure was signi cantly lower in deceased patients (p<0.05). No signi cant correlation was observed between mortality rates and diastolic blood pressure and heart rate (p>0.05). Serum blood urea nitrogen (BUN) and neutrophil levels, RDW/ to platelet (PLT) ratio, NLR, and RDW levels were high, and hemoglobin(HGB) level was signi cantly low in deceased patients(p<0.05). No signi cant correlation was observed between mortality rates and serum PLT and lymphocyte levels (p>0.05) ( Table 3 ). e median Glasgow-Blatchford score was 14 (6) in deceased patients and 11 (7) in surviving patients. e median Glasgow-Blatchford score was signi cantly higher in deceased patients(p<0.05) e most common lesions observed in patients were duodenal and/or peptic ulcers (95.5%); however, no signi cant correlation was observed between the type of lesion and mortality rates (p>0.05). No signi cant correlation was observed between mortality rates and the Forrest classi cation (p>0.05) ( Table 4 ). Multivariate logistic regression analysis showed that age, comorbidities and RDW and NLR values were independently and signi cantly correlated with mortality rates (p<0.05)( Table 5 ). ROC analysis was performed to determine the predictive value of NLR ( Figure 1 ) and RDW ( Figure 2) 
DISCUSSION
Patients presenting with upper GI bleeding show high mortality rates and 80% of these deaths occur from bleeding-related causes. Other leading causes of mortality include terminal malignancy, multiorgan failure and cardiopulmonary decompensation (8, 9) . In our study, age, comorbidities, as well as NLR and RDW values were observed to be independent risk factors a ecting 30-day mortality rates. Neutrophils and lymphocytes increase secondary to GI bleedinginduced in ammationGI. Kandemir et al. reported that leukocytes and NLR were e ective predictors of mortality in patients with GI bleeding (10). Peng et al. reported the prognostic e cacy of NLR in patients with GI bleeding (11) . In our study, the neutrophil count was high, the lymphocyte count was low, and the NLR ratio was high in deceased patients. In our view, the high neutrophil rate and NLR were associated with more severe in ammation in deceased patients.
Isik et al. reported that RDW was increased in patients with GI bleeding and that RDW values were higher in deceased patients than in survivors. is observation was attributed to increased stress in patients (12) . Ozdemir et al. reported that among patients followedup in the intensive care unit, RDW was lower in patients who were discharged and higher in deceased patients (13) . In our study, RDW was higher, the PLT count was similar and the RDW/ PLT ratio was higher in deceased patients, which can be attributed to the fact that RDW was elevated secondary to increased stress.
A study reported by Christensen et al. showed that the 30-day mortality rate was 10.8% in patients with bleeding peptic ulcers (14) . e 30-day mortality rate in patients with upper GI bleeding was 4.5% in a study reported by Marmo (17) . In our study, the 30-day mortality rate was 14.4% (higher than rates reported in the literature), which could be attributed to several factors ranging from social characteristics of patients to the treatment administered. Additionally, it might be related to the fact that patients with mild disease were not referred to our hospital (a tertiary center).
Previous studies have reported that the incidence of upper GI bleeding is higher in elderly patients and it is associated with a higher mortality rate in this age group (15, 18) . A study reported by Sung et al. investigated mortality patterns in those with upper GIS bleeding over a 30-day period, and reported that deceased patients were older (8) . Christensen et al. reported that age was a signi cant and independent factor associated with 30-day mortality rates in patients with complicated peptic ulcers(ulcers associated with bleeding and/ or perforation) (14) . In our study, the mean age of patients was 58.2±17.3 years. We observed that the mean age was higher in deceased patients, and that age was inde-pendantly associated with mortality rates, which could be attributed to increased vascular fragility, decreased cardiac reserve, increased comorbidities and drug use in elderly patients.
A few studies have reported that upper GI bleeding is more common in men (15, 18) . However, Marmo et al. (15) and Sung et al. (8) reported no correlation between the 30-day mortality rates and sex. Our study results were consistent with the literature in that upper GIS bleeding was observed more commonly in men, although no signi cant correlation was observed between mortality rates and sex. In our view, upper GI bleeding occurs more commonly in men because the use of substances such as tobacco and alcohol, as well as antiplatelet and anticoagulants drugs is greater in men secondary to higher occurrence of ischemic events and a more stressful life. However, a patient's clinical condition affects mortality, and a patient's sex is not relevant in this context.
Previous studies have reported that patients most commonly present with melena, although no correlation was observed between melena and mortality rates (19, 20) . Lanas et al. reported that patients with hematemesis were at a higher risk of death (21) . In our study, the most common symptom observed in patients was melena; however, melena was not correlated with mortality rates. In our opinion, melena was the most common symptom in our study because even small quantities of bleeding (50 mL) cause melena. A small quantity or slow chronic bleeding from a lower site in the GI can cause melena. However, we reckon that symptom severity and the quantity of bleeding a ect mortality rates rather than the occurrence of bleeding.
A few studies have reported that comorbidities and the administration of certain drugs increase the incidence of GI (19, 22, 23) . Siddique et al. reported that comorbidities such as stroke and pneumonia were not associated with readmission and mortality; however, cirrhosis and malignancy, among other such conditions, increase the incidence of re-bleeding (24 (21) . In our study, mortality rate was high in patients with comorbidities and in those with malignancy and cirrhosis; however, predisposing factors did not a ect mortality rates. e 30-day mortality rate might be higher in patients with cirrhosis and malignancies because these conditions precipitate bleeding. Cirrhosis causes bleeding secondary to variceal bleeding and reduction in serum levels of coagulation factors is observed in both malignancy and cirrhosis. We concluded that antiplatelet and anticoagulant agents did not a ect the 30-day mortality because their doses were adjusted in this study.
Reportedly, hemodynamic instability is a common factor associated with upper GI bleeding-induced mortality (21, 25, 26) . Marmo et al. reported that heart rate was higher and blood pressure was lower at the time of admission to the hospital in patients who died within 30 days of developing upper GI bleeding (15) . In our study, we observed signi cant hypotension and higher pulse rate in deceased patients, although this di erence was statistically non-signi cant. İt is known that blood pressure reduction is proportionate to bleeding and tachycardia is known to occur in patients with severe bleeding. is non-signi cant result might be attributed to a small number of deceased patients and the use of drugs causing bradycardia. (4) . In our study, most patients were classi ed into grade 3 based on the Forrest classi cation and no correlation was observed between mortality rates and the Forrest classi cation. However, deceased patients showed a higher Glasgow-Blatchford score. We consider quantity of bleeding to be a primary determinant of mortality rather than the features of the bleeding lesion. erefore, theGlasgow-Blatchford score (which predicts the need for hemodynamic intervention) is more useful than the Forrest score. e lack of a signi cant correlation between mortality rates and the Forrest score could be attributed to the fact that active bleeding causes severe and acute blood loss, whereas slow chronic bleeding causes severe losses over time. Additionally, a small number of patients with stage 1 and stage 2 disease who were investigated might have led to this result.
CONCLUSION
In conclusion, several factors a ect 30-day mortality rates in patients with GI bleeding. Clinicians should be aware that elderly patients, those with comorbidities and impaired hemodynamics require careful and long-term follow-up and that these patients are at a high risk for mortality.
LIMITATIONS
Following are the limitations of this study: (1) is was a small-scale study.
(2) Mortality was attributed only to GI bleeding.
(3) Comorbidities and drugs used were evaluated based only on the patients' medical history without analysing documented data regarding the duration of disease and drug use. (4) Although eradication of Helicobacter pylori decreases bleeding in patients with peptic ulcer, we could not analyse the presence of this organism in our study population.
